COCM yields 2000000.00% · ABBV yields 3.06%● Live data
📍 COCM pulled ahead of the other in Year 1
Combined, COCM + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of COCM + ABBV for your $10,000?
Comerton Corp. provides information technology (IT) consulting and outsourcing services to Canadian government and private sector clients. It offers consulting services in the areas of IT services, IT security, knowledge management, and audit and management consulting. The company's IT services include IT consulting services comprising IT architecture, GIS systems, outsourcing services, database development/data warehousing, and project management/team leadership; application development; systems integration; and Web presence. Its IT security services consist of privacy impact assessment, threat and risk assessment, statement of sensitivity, emergency preparedness, and business continuity planning. Spearhead's knowledge and information management services comprise knowledge management strategic planning; operations management, business process, and workflows; and RDIMS solution that integrates records management, document management, imaging, optical character recognition, full-text indexing search and retrieval, workflow, an on-line document viewer and reporting capabilities. It also provides a range of audit services, such as comprehensive audits, grant and contribution audits, information management and technology audits, public financial attest audits, and result based audit framework; and management consulting services consisting of revenue management, financial services, human resource services, operational reviews, organizational reviews, risk management, and results-based management and accountability frameworks. The company was formerly known as Heritage Printing Technology Corp. The company is headquartered in Boca Raton, Florida.
Full COCM Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.